TMC Pharma Services Ltd is a dynamic player in the pharmaceutical services sector, known for its slogan, "Your strategic partner in advancing patient health." Founded in 2000, the company is headquartered in the United Kingdom and operates primarily within the Biotechnology, Health Care, and Pharmaceutical industries.
With a focus on enhancing the speed and value of drug development, TMC partners with small to mid-sized biotech and pharma firms to shepherd projects from clinical development to market access. Their comprehensive services range from clinical execution to drug commercialization, backed by cross-functional teams proficient in regulatory affairs, clinical development, and pharmacovigilance.
Their adaptability and insight into rare diseases and new therapeutic modalities make them an attractive collaborator, especially for companies targeting EU and UK markets. TMC's growth is underscored by a recent £18.00M Private Equity Round led by investor LDC on 08 August 2022, marking a significant endorsement of their market positioning and capabilities.